Cosmetic peptide · expression lines
Acetyl hexapeptide-8 (Ac-EEMQRR-NH2), the cosmetic ingredient marketed as Argireline, is six amino acids long. Its developers arrived at it through a rational design program looking for a non-toxic molecule that could imitate botulinum toxin's effect on wrinkles1. The sequence borrows a short stretch of SNAP-25, a protein at nerve endings, and the peptide is applied to the skin in products aimed at expression lines.
Muscle contraction depends on nerve endings releasing chemical messengers, a step driven by a protein bundle called the SNARE complex, which includes SNAP-25. Acetyl hexapeptide-8 copies the starting (N-terminal) segment of SNAP-25. In cell and test-tube experiments it interfered with formation of the SNARE complex and reduced neurotransmitter release, which its developers likened to the action of botulinum toxin, though with a much smaller maximum effect1,2. Whether enough peptide reaches nerve endings under intact skin is uncertain: in a lab study on donor human skin and hairless guinea pig skin, most of the applied peptide washed off the surface, a small fraction stayed in the outermost layer, and none was detected in the dermis4.
Human evidence is limited to small, short cosmetic studies. The developers reported that a cream containing the peptide reduced wrinkle depth by up to 30% after 30 days in healthy women, alongside their cell work1. In a randomized, placebo-controlled study of 60 Chinese adults, four weeks of application around the eyes produced a rated improvement in 48.9% of the peptide group versus none on placebo, and silicone-replica roughness measures fell only in the peptide group2.
A 2023 split-face study of 19 women found no statistically significant difference between a hyaluronic acid serum with the peptide and the same type of serum without it, measured by camera-based skin analysis3. Skin-penetration work suggests very little of the peptide gets past the surface layer4. No large, independent, long-term trials have been published.
Acetyl hexapeptide-8 is not approved as a drug anywhere. It is used as a cosmetic ingredient, and an expert panel that reviews cosmetic ingredients has assessed it for that use5.
There is no formal clinical side-effect profile. The developers reported no primary skin irritation in early testing1, and the 2023 split-face study recorded no significant adverse events, allergic reactions or skin irritation3. A cosmetic-ingredient expert panel found it acceptable at the low concentrations currently reported in products, but judged the data insufficient for higher concentrations5. One case report described a mycobacterial infection with abscesses after the peptide was injected into the forehead and temples, a use it was not designed for6.
This page is educational reference material about compounds studied in research settings. It is not medical advice, and nothing here is a recommendation to buy, possess, or use any compound. Research findings described are from published literature; individual compounds may not be approved for human use. Talk to a licensed clinician about anything that affects your health.
Brand names on this page belong to their owners and are used only to identify a product. goodtides is not affiliated with those companies.